NEW YORK June 6, 2011 /PRNewswire/ — SuperGen, Inc. (NASDAQ:
SUPG), a pharmaceutical company dedicated to the discovery and
development of novel cancer therapies, today announced their June
2nd RetailInvestorConferences.com presentation is available for
> Click the red “register/ watch event now” button.
SuperGen’s presentation will be available 24/7 for 90 days.
Investors may download shareholder materials from the “virtual
trade booth” for the next three weeks.
SuperGen is a pharmaceutical company dedicated to discovery and
development of novel cancer therapeutics in epigenetic and cell
signaling modulation. The Company develops products through
biochemical and clinical proof of concept to partner for further
development and commercialization. On April 6, 2011, SuperGen
entered into a definitive merger agreement to acquire Astex
Therapeutics Limited, a UK based biotechnology company. The
transaction is subject to customary regulatory, legal and
shareholder approvals. For more information about SuperGen, please
RetailInvestorConferences.com, created by BetterInvesting
(NAIC), PR Newswire and MUNCmedia, is the first
monthly virtual investor conference series that provides an
interactive forum for presenting companies to meet directly with